SCHEMBL13684205

SCHEMBL13684205

CCN(C(=O)OCc1ccccc1)C(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.51
L3MBTL1 Q9Y468 5/20 0.50
LMNA P02545 3/20 0.50
POLB P06746 1/20 0.50
HSD17B10 Q99714 1/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
ABCB1 P08183 1/20 0.44
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
CCR6 P51684 1/20 0.43
PAX8 Q06710 1/20 0.43
ATM Q13315 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7453248 0.88 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL15564386 0.88 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL18980750 0.88 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL6991879 0.86 ALDH1A1 (0.50) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL17956525 0.86 ALDH1A1 (0.50) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL22122328 0.85 ALDH1A1 (0.56) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL20794168 0.85 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL22122326 0.85 ALDH1A1 (0.56) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL12130679 0.84 KMT2A (0.50) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL18154139 0.84 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNAPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9988377-B2 Small molecule inducers of GDNF as potential new therapeutics for neuropsychiatric disorders THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-06-05 US disclosed
US-7589204-B2 Indane compounds as CCR5 antagonists SMITHKLINE BEECHAM CORPORATION (US) 2009-09-15 US disclosed
US-7531661-B2 Indane compounds as CCR5 antagonists SMITHKLINE BEECHAM CORPORATION (US) 2009-05-12 US disclosed